tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Esperion (ESPR)
NASDAQ:ESPR
US Market
ESPR
Esperion
RESEARCH TOOLSreports

Esperion (ESPR) Stock News & Sentiment

Compare
1,657 Followers
Esperion Therapeutics Flags Material Weakness in Financial Controls, Raising Reporting and Regulatory Risks
Premium
Company Announcements
Esperion Therapeutics Flags Material Weakness in Financial Controls, Raising Reporting and Regulatory Risks
11d ago
ESPR
Esperion Therapeutics: Strong 2025 Execution, Expanding Cardiometabolic Platform, and Vision 2040 Underpin Buy Rating
Premium
Ratings
Esperion Therapeutics: Strong 2025 Execution, Expanding Cardiometabolic Platform, and Vision 2040 Underpin Buy Rating
12d ago
ESPR
Options Volatility and Implied Earnings Moves Today, March 10, 2026
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 10, 2026
12d ago
FNV
KSS
Balanced Risk-Reward Keeps Esperion at Hold Amid Complex Corstasis Acquisition and CHF Market Challenges
Premium
Ratings
Balanced Risk-Reward Keeps Esperion at Hold Amid Complex Corstasis Acquisition and CHF Market Challenges
18d ago
ESPR
Esperion to Acquire Corstasis, Expanding Heart Failure Portfolio
Premium
Company Announcements
Esperion to Acquire Corstasis, Expanding Heart Failure Portfolio
19d ago
8K
ESPR
ESPR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ESPR Earnings this Week: How Will it Perform?
28d ago
ESPR
Esperion Therapeutics: Strengthened Bempedoic Acid Patent Protection and Growing Cardiovascular Franchise Support Buy Rating
Premium
Ratings
Esperion Therapeutics: Strengthened Bempedoic Acid Patent Protection and Growing Cardiovascular Franchise Support Buy Rating
1M ago
ESPR
More ESPR News >

ESPR News on the Web

Esperion Insiders Quietly Cash Out as Top Executives Trim Their Stakes
TipRanks News
Neutral
Piper Sandler Reaffirms Their Buy Rating on Esperion (ESPR)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM), Stryker (SYK) and Esperion (ESPR)
TipRanks News
Bearish
Analysts Are Bullish on Top Healthcare Stocks: HeartBeam (BEAT), Structure Therapeutics, Inc. Sponsored ADR (GPCR)
TipRanks News
Neutral
Analysts’ Top Healthcare Picks: Esperion (ESPR), NovaBridge Biosciences (NBP)
TipRanks News
Bullish
Esperion says bempedoic acid receives recommendations in ACC/AHA Guideline
TipRanks News
Bullish
Esperion price target raised to $5 from $4 at Citizens
TipRanks News
Bullish
Esperion Therapeutics Flags Material Weakness in Financial Controls, Raising Reporting and Regulatory Risks
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
ESPR
Sector Average
Media Buzz
This Week6 articles
Weekly Average8.75 articles
News Sentiment
This Week67%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ESPR’s Media Buzz Sentiment?
6 articles about ESPR were published this week. In an average week, 8.75 articles are published.
    What is ESPR’s weekly average amount of articles?
    In an average week, 8.75 articles about ESPR are published.
      What is ESPR’s News Sentiment?
      67% of articles about ESPR were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        KHTRFKnight Therapeutics
        ABOSAcumen Pharmaceuticals
        KMTSKestra Medical Technologies Ltd.
        MISTMilestone Pharmaceuticals
        OVIDOvid Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week